JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB220162

Anti-YTHDF1 antibody [EPR22349-41]

Be the first to review this product! Submit a review

|

(35 Publications)

Anti-YTHDF1 antibody [EPR22349-41] (ab220162) is a rabbit monoclonal antibody detecting YTHDF1 in Western Blot, IP. Suitable for Human, Mouse, Rat.

- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 10 publications

View Alternative Names

C20orf21, YTHDF1, YTH domain-containing family protein 1, DF1, Dermatomyositis associated with cancer putative autoantigen 1, DACA-1

6 Images
Immunoprecipitation - Anti-YTHDF1 antibody [EPR22349-41] (AB220162)
  • IP

Unknown

Immunoprecipitation - Anti-YTHDF1 antibody [EPR22349-41] (AB220162)

YTHDF1 was immunoprecipitated from 0.35 mg HepG2 (Human hepatocellular carcinoma epithelial cell) whole cell lysate with ab220162 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab220162 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/5000 dilution.
Lane 1 : HepG2 whole cell lysate 10 μg (Input).
Lane 2 : ab220162 IP in HepG2 whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab220162 in HepG2 whole cell lysate.
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure time : 3 seconds.

Lysate were made freshly and used in IP test immediately to minimize protein degradation. Incubation time was 2h.

All lanes:

Immunoprecipitation - Anti-YTHDF1 antibody [EPR22349-41] (ab220162)

Predicted band size: 61 kDa

false

Immunoprecipitation - Anti-YTHDF1 antibody [EPR22349-41] (AB220162)
  • IP

Supplier Data

Immunoprecipitation - Anti-YTHDF1 antibody [EPR22349-41] (AB220162)

YTHDF1 was immunoprecipitated from HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate with ab220162 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab220162 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/5000 dilution. Lane 1 : HeLa whole cell lysate 10 μg (Input). Lane 2 : ab220162 IP in HeLa whole cell lysate. Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab220162 in HeLa whole cell lysate. Blocking/Dilution buffer : 5% NFDM/TBST. Lysate was freshly made and used for Western blotting immediately to minimize protein degradation.

All lanes:

Immunoprecipitation - Anti-YTHDF1 antibody [EPR22349-41] (ab220162) at 1/1000 dilution

All lanes:

HeLa whole cell lysate at 10 µg

Predicted band size: 61 kDa

Observed band size: 60 kDa

false

Exposure time: 8s

Western blot - Anti-YTHDF1 antibody [EPR22349-41] (AB220162)
  • WB

Unknown

Western blot - Anti-YTHDF1 antibody [EPR22349-41] (AB220162)

The wild-type and YTHDF1 knockout cell lysates were kindly provided by an anonymous collaborator.

ab220162 was shown to specifically react with YTHDF1 in wild-type mESC cells as signal was lost in YTHDF1 knockout cells. Wild-type and YTHDF1 knockout samples were subjected to SDS-PAGE. ab220162 and ab181602 (Rabbit anti-GAPDH loading control) were incubated 1 hour at room temperature at 1/1000 dilution and 1/200,000 dilution respectively. Blots were developed with Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) secondary antibody at 1/100,000 dilution for 1 hour at room temperature before imaging. The blot was developed on a BIO-RAD® ChemiDoc™ MP instrument using the ECL technique.

Exposure times : Lanes 1 and 2 : 59 seconds; Lanes 3 and 4 : 26 seconds.

Blocking/Dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-YTHDF1 antibody [EPR22349-41] (ab220162) at 1/1000 dilution

Lane 1:

Wild-type mESC (mouse embryo stem cell) whole cell lysate at 20 µg

Lane 2:

YTHDF1 knockout mESC whole cell lysate at 20 µg

Lane 3:

HepG2 (human hepatocellular carcinoma epithelial cell) whole cell lysate at 20 µg

Lane 4:

HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 61 kDa

Observed band size: 61 kDa

false

Western blot - Anti-YTHDF1 antibody [EPR22349-41] (AB220162)
  • WB

Supplier Data

Western blot - Anti-YTHDF1 antibody [EPR22349-41] (AB220162)

Lysates were freshly made and used for Western blotting immediately to minimize protein degradation. Blocking and diluting buffer and concntration : 5% NFDM/TBST Imaging carried out using iBright CL 1000 Imaging System

All lanes:

Western blot - Anti-YTHDF1 antibody [EPR22349-41] (ab220162) at 1/1000 dilution

Lane 1:

HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate at 20 µg

Lane 2:

293T (human embryonic kidney epithelial cell) whole cell lysate at 20 µg

Lane 3:

NIH/3T3 (mouse embryonic fibroblast) whole cell lysate at 20 µg

Lane 4:

PC-12 (rat adrenal gland pheochromocytoma cell) whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 61 kDa

Observed band size: 60 kDa

false

Exposure time: 180s

Western blot - Anti-YTHDF1 antibody [EPR22349-41] (AB220162)
  • WB

Unknown

Western blot - Anti-YTHDF1 antibody [EPR22349-41] (AB220162)

The YTHDF recombinant proteins were kindly provided by an anonymous collaborator.

Blocking/Dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-YTHDF1 antibody [EPR22349-41] (ab220162) at 1/1000 dilution

Lane 1:

GST-tagged human YTHDF1 recombinant protein, 20 ng

Lane 2:

GST-tagged human YTHDF2 recombinant protein, 20 ng

Lane 3:

GST-tagged human YTHDF3 recombinant protein, 20 ng

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 61 kDa

Observed band size: 87 kDa

false

Exposure time: 3s

Western blot - Anti-YTHDF1 antibody [EPR22349-41] (AB220162)
  • WB

CiteAb

Western blot - Anti-YTHDF1 antibody [EPR22349-41] (AB220162)

YTHDF1 western blot using anti-YTHDF1 antibody [EPR22349-41] ab220162. Publication image and figure legend from Jin, D., Guo, J., et al., 2020, Mol Cancer, PubMed 32106857.

ab220162 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab220162 please see the product overview.

YTHDF1 and YTHDF2 competitively interacted with YTHDF3 in an m6A- independent manner to regulate YAP expression. (a) The diagram of that YTHDF1 and YTHDF2 competitively interacted with YTHDF3 to regulate YAP expression in NSCLC. (b, c) The interaction between YTHDF1/2/3 and YAP mRNA was determined by RIP assay. (d) The interactions between YTHDF1/YTHDF2 and the mRNA of YAP were increased when YTHDF3 is existed determined by RNA pulldown assay. (e) Western blot analysis indicated that FTO and ALKBH5 were only in nuclear fractions but YTHDF1/2/3 were only in cytoplasm fractions in A549 cells. (f, g) Immunofluorescent staining showed that ALKBH5 WT/KD were only in nuclear fractions (f) but YTHDF1/2/3 were only in cytoplasm fractions (g) in A549 cells. (h) Co-IPs performed using lysates collected from A549 cells with immunoprecipitation by either YTHDF1, YTHDF2 or YTHDF3 antibodies. (i) The protein level of YTHDF3 was analyzed in lysates collected from either YTHDF1 or YTHDF2 transfected A549 and H1299 cells determined by Co-IPs assays by immunoprecipitation with YTHDF2 or YTHDF1 antibodies, respectively. (j, k) The interactions between YTHDF1/2/3 and YAP mRNA were detected in A549 and H1299 cells with transfection with indicated genes determined by Co-IP assay using the MS2 coat protein system. (l) The interactions between YTHDF1/2 and YAP mRNA was determined by RIP assay in A549 and H1299 cells with transfection of indicated genes. (m) The m6A levels of YAP were analyzed by in A549 and H1299 cells with transfection into indicated genes. (n) The protein level of YTHDF3 was detected in lysates collected from A549 cells determined by Co-IP assay with immunoprecipitation with either YTHDF1 or YTHDF2 antibodies. Results were presented as mean ± SD of three independent experiments. *p < 0.05 or **p < 0.01 indicates a significant difference between the indicated groups. ns, not significant

false

  • Carrier free

    Anti-YTHDF1 antibody [EPR22349-41] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR22349-41

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Rat, Human

Applications

IP, WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/30", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>" }, "Mouse": { "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>" }, "Rat": { "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>" }, "Recombinant fragment - Human": { "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>" } } }

Product details

What is this antibody validated in?
Anti-YTHDF1 antibody [EPR22349-41] (ab220162) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunoprecipitation (IP) in Human, Mouse, Rat samples.

What is the molecular weight of YTHDF1?
Anti-YTHDF1 [EPR22349-41] (ab220162) specifically detects a band for YTHDF1 (UniProt: Q9BYJ9) at a molecular weight of 61kDa.

Trusted by the scientific community
Anti-YTHDF1 [EPR22349-41] (ab220162) was first used in a scientific publication in 2019 and has been cited over 10 times in peer-reviewed journals.

Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.

Specificity confirmed
The specificity of Anti-YTHDF1 antibody [EPR22349-41] (ab220162) has been confirmed by Western blot testing in YTHDF1 Knockout mESC cells.

Other related products
We have a range of other formats of antibody clone [EPR22349-41] also available for your convenience: ab220162, Carrier free - ab253038

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

YTHDF1 also known as YTH domain family protein 1 is a reader protein of N6-methyladenosine (m6A) a common RNA modification. Its mass is approximately 64 kDa. YTHDF1 binds to m6A-modified mRNA and enhances its translation efficiency by recruiting ribosomes. This protein is present in various tissues showing higher expression in brain spleen and lymphoid tissues suggesting a role in development and immunity.
Biological function summary

YTHDF1 affects mRNA stability and translation providing a mechanism for regulating protein synthesis. It operates as part of a complex with other m6A readers like YTHDF2 and YTHDF3 which determine mRNA fate. By promoting translation YTHDF1 impacts cellular responses and adaptation to environmental changes especially during stress and division.

Pathways

YTHDF1 integrates into the mRNA surveillance pathway and translation regulation. It interacts closely with other components such as eukaryotic initiation factors (eIFs) to modulate protein synthesis dynamics. This allows cells to rapidly adjust protein levels in response to cues and maintain homeostasis. Its role is critical in link to ribosomal function and stability of gene expression networks.

YTHDF1 has connections to cancer and neurological disorders. In cancer abnormal YTHDF1 expression associates with tumor progression and metastasis and interacts with proteins like METTL3 involved in m6A deposition. In neurological disorders dysregulation of YTHDF1 influences mRNA translation tied to cognitive functions possibly interacting with neurotransmitter pathways. Understanding these roles shows potential for YTHDF1 as a therapeutic target.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Specifically recognizes and binds N6-methyladenosine (m6A)-containing mRNAs, and regulates their stability (PubMed : 24284625, PubMed : 26318451, PubMed : 32492408). M6A is a modification present at internal sites of mRNAs and some non-coding RNAs and plays a role in mRNA stability and processing (PubMed : 24284625, PubMed : 32492408). Acts as a regulator of mRNA stability by promoting degradation of m6A-containing mRNAs via interaction with the CCR4-NOT complex (PubMed : 32492408). The YTHDF paralogs (YTHDF1, YTHDF2 and YTHDF3) shares m6A-containing mRNAs targets and act redundantly to mediate mRNA degradation and cellular differentiation (PubMed : 28106072, PubMed : 32492408). Required to facilitate learning and memory formation in the hippocampus by binding to m6A-containing neuronal mRNAs (By similarity). Acts as a regulator of axon guidance by binding to m6A-containing ROBO3 transcripts (By similarity). Acts as a negative regulator of antigen cross-presentation in myeloid dendritic cells (By similarity). In the context of tumorigenesis, negative regulation of antigen cross-presentation limits the anti-tumor response by reducing efficiency of tumor-antigen cross-presentation (By similarity). Promotes formation of phase-separated membraneless compartments, such as P-bodies or stress granules, by undergoing liquid-liquid phase separation upon binding to mRNAs containing multiple m6A-modified residues : polymethylated mRNAs act as a multivalent scaffold for the binding of YTHDF proteins, juxtaposing their disordered regions and thereby leading to phase separation (PubMed : 31292544, PubMed : 31388144, PubMed : 32451507). The resulting mRNA-YTHDF complexes then partition into different endogenous phase-separated membraneless compartments, such as P-bodies, stress granules or neuronal RNA granules (PubMed : 31292544).
See full target information YTHDF1

Publications (35)

Recent publications for all applications. Explore the full list and refine your search

Cell biology international 49:1290-1300 PubMed40600388

2025

YTHDF1-Mediated mA Methylation of GLUT1 Promotes Progress and Suppresses Propranolol Sensitivity in Infantile Hemangioma.

Applications

Unspecified application

Species

Unspecified reactive species

Yunfeng Du,Pengyuan Li,Xianghong Du

Virus research 358:199590 PubMed40480313

2025

Enterovirus 71 structural viral protein 1 promotes the expression of PMP22 through mA modification in mouse Schwann cells.

Applications

Unspecified application

Species

Unspecified reactive species

Qiuyan Peng,Guangming Liu,Danping Zhu,Suyun Li,Sida Yang,Peiqing Li,Yingxian Yin,Dandan Hu

Renal failure 47:2497492 PubMed40325507

2025

METTL3 promotes podocyte pyroptosis in diabetic nephropathy through N-methyladenosine modification of TRIM29 mRNA.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaohong Xu,Xiaolin Huang,Ce Zhang,Xia Mi,Chi Zhang,Fei Hua,Liexiang Zhang

Cell death discovery 11:210 PubMed40301310

2025

Acetylated KIAA1429 by TIP60 facilitates metastasis and immune evasion of hepatocellular carcinoma via N6-methyladenosine-KDM5B-mediated regulation of FoxO1.

Applications

Unspecified application

Species

Unspecified reactive species

Hu Quan,Huijun Zhou,Fei Chen,Jie Chen,Yun He,Hua Xiao,Jia Liu,Lei Shi,Wei Xie,Pan Chen,Jia Luo

Diabetic medicine : a journal of the British Diabetic Association 42:e70033 PubMed40210448

2025

m6A demethylase ALKBH5 reduces ferroptosis in diabetic retinopathy through the m6A-YTHDF1-ACSL4 axis.

Applications

Unspecified application

Species

Unspecified reactive species

Qinghui Liao,Yan Li,Meijing Cui,Min Liu

Molecular medicine (Cambridge, Mass.) 30:267 PubMed39716068

2024

RBM15-dependent m6A modification mediates progression of non-small cell lung cancer cells.

Applications

Unspecified application

Species

Unspecified reactive species

Man Wang,Yujiao Qin,Xiaoqi Ai,Xiuhua Liu

Cell biology and toxicology 40:58 PubMed39060874

2024

KIAA1429 increases FOXM1 expression through YTHDF1-mediated m6A modification to promote aerobic glycolysis and tumorigenesis in multiple myeloma.

Applications

Unspecified application

Species

Unspecified reactive species

Yue Wu,Yi Luo,Xingchen Yao,Xiangjun Shi,Ziyu Xu,Jie Re,Ming Shi,Meng Li,Junpeng Liu,Youzhi He,Xinru Du

Molecular cancer 22:202 PubMed38087322

2023

A positive feedback circuit driven by mA-modified circular RNA facilitates colorectal cancer liver metastasis.

Applications

Unspecified application

Species

Unspecified reactive species

Kaixuan Zeng,Jianhong Peng,Yue Xing,Linjie Zhang,Peishan Zeng,Weihao Li,Weili Zhang,Zhizhong Pan,Chi Zhou,Junzhong Lin

Cell stem cell 30:1658-1673.e10 PubMed38065069

2023

SON is an essential mA target for hematopoietic stem cell fate.

Applications

Unspecified application

Species

Unspecified reactive species

Hanzhi Luo,Mariela Cortés-López,Cyrus L Tam,Michael Xiao,Isaac Wakiro,Karen L Chu,Aspen Pierson,Mandy Chan,Kathryn Chang,Xuejing Yang,Daniel Fecko,Grace Han,Eun-Young Erin Ahn,Quaid D Morris,Dan A Landau,Michael G Kharas

Molecular cell 83:4304-4317.e8 PubMed37949069

2023

FMRP phosphorylation modulates neuronal translation through YTHDF1.

Applications

Unspecified application

Species

Unspecified reactive species

Zhongyu Zou,Jiangbo Wei,Yantao Chen,Yunhee Kang,Hailing Shi,Fan Yang,Zhuoyue Shi,Shijie Chen,Ying Zhou,Caraline Sepich-Poore,Xiaoxi Zhuang,Xiaoming Zhou,Hualiang Jiang,Zhexing Wen,Peng Jin,Cheng Luo,Chuan He
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com